Cargando…

Prognostic Values of TIGAR Expression and (18)F-FDG PET/CT in Clear Cell Renal Cell Carcinoma

Aim: Evaluation of (18)F-FDG accumulation using PET/CT is an potential imaging biomarker to reflect tumor metabolic burdens and to help predict prognosis in renal cell carcinoma (RCC). p53-induced glycolysis and apoptosis regulator (TIGAR) is a protein regulates glycolytic activity and glucose metab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaoyan, Li, Rui, Chen, Ruohua, Huang, Gang, Zhou, Xiang, Liu, Jianjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930409/ https://www.ncbi.nlm.nih.gov/pubmed/31892967 http://dx.doi.org/10.7150/jca.33442

Ejemplares similares

The Role of (18)F-FDG PET/CT in the Evaluation of Peritoneal Thickening of Undetermined Origin
por: Chen, Ruohua, et al.
Publicado: (2016)

Fructose 1,6-Bisphosphatase 1 Expression Reduces (18)F-FDG Uptake in Clear Cell Renal Cell Carcinoma
por: Chen, Ruohua, et al.
Publicado: (2019)

Delayed (18)F-FDG PET/CT Appearance of Urachal Adenocarcinomas
por: Xu, Lian, et al.
Publicado: (2020)

Preoperative PET/CT (18)F-FDG Standardized Uptake by Lymph Nodes as a Significant Prognostic Factor in Patients with Colorectal Cancer
por: Chen, Ruohua, et al.
Publicado: (2018)

Prognostic values of ALDOB expression and (18)F-FDG PET/CT in hepatocellular carcinoma
por: Jia, Wenzhi, et al.
Publicado: (2022)

Delayed post-diuretic (18)F-FDG PET/CT for preoperative evaluation of renal pelvic cancer
por: Shi, Yiping, et al.
Publicado: (2020)

TIGAR Is Correlated with Maximal Standardized Uptake Value on FDG-PET and Survival in Non-Small Cell Lung Cancer
por: Zhou, Xiang, et al.
Publicado: (2013)

Preoperative evaluation of residual tumor in patients with endometrial carcinoma by using (18)F-FDG PET/CT
por: Wu, Chunhua, et al.
Publicado: (2020)

Prognostic Values of Baseline (18)F-FDG PET/CT in Patients with Peripheral T-Cell Lymphoma
por: Zhou, Yeye, et al.
Publicado: (2020)

Prognostic value of pretreatment (18)F-FDG PET-CT for nasopharyngeal carcinoma patients
por: Huang, Yecai, et al.
Publicado: (2017)

The Prognostic Value of (18)F-FDG PET/CT and KRAS Mutation in Colorectal Cancers
por: Arslan, Esra, et al.
Publicado: (2020)

The Prognostic and Diagnostic Value of [(18)F]FDG PET/CT in Untreated Laryngeal Carcinoma
por: Al-Ibraheem, Akram, et al.
Publicado: (2023)

Prognostic value of (18)F-FDG PET/CT metabolic parameters in small cell lung cancer
por: Choi, Eun Kyoung, et al.
Publicado: (2019)

The Incremental Prognostic Value of Baseline (18)F-FDG PET/CT Imaging in Angioimmunoblastic T-Cell Lymphoma
por: Wang, Hui, et al.
Publicado: (2020)

(18)F-FDG PET/CT-based metabolic metrics in recurrent tumors of ovarian clear cell carcinoma and their prognostic implications
por: Ye, Shuang, et al.
Publicado: (2019)

Use of (68)Ga-PSMA-11 and (18)F-FDG PET-CT Dual-Tracer to Differentiate Between Lymph Node Metastases and Ganglia
por: Shi, Yiping, et al.
Publicado: (2021)

Prognostic Value of (18)F-FDG PET-CT in Nasopharyngeal Carcinoma: Is Dynamic Scanning Helpful?
por: Huang, Bingsheng, et al.
Publicado: (2015)

Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
por: Jo, In Young, et al.
Publicado: (2015)

Prognostic values of mid-radiotherapy (18)F-FDG PET/CT in patients with esophageal cancer
por: Kim, Nalee, et al.
Publicado: (2019)

Diagnostic and prognostic value of F-18 FDG PET/CT in patients with carcinoma of unknown primary
por: Bicakci, Nilufer
Publicado: (2022)

Diagnostic Value of (18)F-FDG-PET/CT in Patients with FUO
por: Georga, Stamata, et al.
Publicado: (2020)

Value of 18-F-FDG PET/CT and CT in the Diagnosis of Indeterminate Adrenal Masses
por: Launay, Nathalie, et al.
Publicado: (2015)

Prognostic Value of Heterogeneity Index Derived from Baseline (18)F-FDG PET/CT in Mantle Cell Lymphoma
por: Liu, Fei, et al.
Publicado: (2022)

The Prognostic Value of (18)F-FDG PET/CT for Hepatocellular Carcinoma Treated with Transarterial Chemoembolization (TACE)
por: Ma, Wenhui, et al.
Publicado: (2014)

Prognostic value of (18)F-FDG PET/CT parameters and histopathologic variables in head and neck cancer
por: Aslan, Hale, et al.
Publicado: (2019)

Diagnostic performance and prognostic value of preoperative (18)F-FDG PET/CT in renal cell carcinoma patients with venous tumor thrombus
por: Chen, Silu, et al.
Publicado: (2022)

(11)C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to (18)F-FDG PET/CT and Prognostic Value
por: Morales-Lozano, Maria I., et al.
Publicado: (2022)

Renal Cell Carcinoma with Paraneoplastic Manifestations: Imaging with CT and F-18 FDG PET/CT
por: Nguyen, Ba D., et al.
Publicado: (2015)

Meta-analysis of the diagnostic value of (18)F-FDG PET/CT in the recurrence of epithelial ovarian cancer
por: Wang, Xiaoyan, et al.
Publicado: (2022)

Value of (18)F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With (18)F-FDG PET/CT, MRI, and Contrast-Enhanced CT
por: Wang, Fei, et al.
Publicado: (2022)

The Heterogeneous Metabolic Patterns of Ganglia in (68)Ga-PSMA, (11)C-choline, and (18)F-FDG PET/CT in Prostate Cancer Patients
por: Shi, Yiping, et al.
Publicado: (2021)

Diagnostic value of (18)F-FDG-PET/CT in benign lung diseases
por: Ergonul, Ayse Gul, et al.
Publicado: (2018)

Differential diagnostic value of (18)F-FDG PET/CT in osteolytic lesions
por: Li, Xiaomeng, et al.
Publicado: (2020)

Relationship between PD-L1 expression and (18)F-FDG uptake in gastric cancer
por: Chen, Ruohua, et al.
Publicado: (2019)

Prognostic Significance of (18)F-FDG PET/CT Imaging in Survival Outcomes in Patients with Renal Cell Carcinoma
por: Tatar, Gamze, et al.
Publicado: (2022)

Prognostic significance of preoperative (18)F-FDG PET/CT in uterine leiomyosarcoma
por: Park, Jeong-Yeol, et al.
Publicado: (2017)

Hypermetabolic Hurthle Cell Adenoma on (18)F-FDG PET/CT
por: Hassan, Aamna, et al.
Publicado: (2018)

Application of (18)F-FDG PET/CT in Langerhans Cell Histiocytosis
por: Liao, Fengxiang, et al.
Publicado: (2022)

Preoperative Evaluation of Renal Cell Carcinoma by Using 18F-FDG PET/CT
por: Takahashi, Miwako, et al.
Publicado: (2015)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vippc4oa86922v6e27dvgb8cge